The 60-second version of Vaxfab Enterprises Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
No clear supporting case emerges from the available numbers.
| Metric | FY23 | FY24 | FY25 | FY26 | 3Y CAGR |
|---|---|---|---|---|---|
| Revenue | ₹17 Cr | ₹9 Cr | ₹59 Cr | ₹94 Cr | +77.8% |
| EBITDA | ₹0 Cr | ₹0 Cr | -₹0 Cr | ₹1 Cr | +27.3% |
| EBITDA Margin | 2.8% | 0.5% | -0.3% | 1.0% | — |
| PAT (Net Profit) | ₹0 Cr | -₹4 Cr | ₹0 Cr | ₹4 Cr | +121.6% |
| EPS | ₹1.7 | ₹-4.25 | ₹0.4 | ₹4.33 | +36.6% |
| ROE | 2.0% | -27.8% | 2.5% | 8.4% | — |
| ROCE | 2.8% | -32.6% | 3.4% | 11.7% | — |
| Total Debt | ₹0 Cr | ₹0 Cr | ₹8 Cr | ₹44 Cr | +406.5% |
| Free Cash Flow | ₹2 Cr | -₹7 Cr | -₹6 Cr | ₹13 Cr | +91.5% |
| Company | P/E | ROE |
|---|---|---|
| MARUTI SUZUKI INDIA LTD. | 25.2x | 13.4% |
| TITAN COMPANY LIMITED | 68.5x | 36.7% |
| TRENT LTD | 87.2x | 25.9% |
| AVENUE SUPERMARTS LIMITED | 69.9x | 12.7% |
A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 2 high-severity red flags sit above this conclusion and should be read first.